Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

enVVeno Medical Corporation (NVNO)

Compare
2.3800
+0.0400
+(1.71%)
At close: 4:00:01 PM EDT
2.3800
0.00
(0.00%)
After hours: 4:05:06 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for NVNO

Recent News: NVNO

View More
enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment

enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment
ACCESS Newswire 9 hours ago
The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium

The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium
ACCESS Newswire 16 days ago
enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25

enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25
ACCESS Newswire last month
enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
ACCESS Newswire last month
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum

One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
ACCESS Newswire last month
Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting

Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting
ACCESS Newswire 2 months ago
Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth

Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth
Simply Wall St. 2 months ago
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe

enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
ACCESS Newswire 3 months ago
enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website

enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website
ACCESS Newswire 4 months ago
enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
ACCESS Newswire 4 months ago
enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
ACCESS Newswire 4 months ago
View More

Related Tickers

IRIX IRIDEX Corporation
1.0300
+3.00%
 
VREX Varex Imaging Corporation
7.16
-6.16%
 
SGHT Sight Sciences, Inc.
2.6100
+3.57%
 
IINN Inspira Technologies Oxy B.H.N. Ltd.
0.6122
+0.69%
 
NMTC NeuroOne Medical Technologies Corporation
0.5646
+4.56%
 
PRCT PROCEPT BioRobotics Corporation
52.81
-0.21%
 
SSKN STRATA Skin Sciences, Inc.
2.5216
-3.76%
 
ECOR electroCore, Inc.
5.98
-3.70%
 
SRTS Sensus Healthcare, Inc.
4.7200
+1.51%
 
DCTH Delcath Systems, Inc.
11.55
+1.32%